Sepsis Alliance AMR Conference

5 (3 votes)


Sepsis Alliance’s 2023 publication, The Healthcare C-Suite AMR Market Report found that only 26% of U.S. healthcare leaders grade themselves an ‘A’ on their hospital or health system’s antimicrobial resistance (AMR) efforts. The Sepsis Alliance AMR Conference aims to provide the tools and knowledge to improve these AMR efforts.

Sepsis and the emergence of antimicrobial resistance (AMR) are intricately intertwined and pose significant challenges. Primary reliance on broad-spectrum antimicrobials is often the initial approach in sepsis treatment, yet, curbing unnecessary antimicrobial use is imperative in combating the escalating threat of AMR.

As AMR intensifies, the likelihood of infections progressing to sepsis increases, rendering sepsis cases progressively more resistant to treatment and consequently subjecting patients to adverse outcomes such as amputations and fatalities. Effectively managing this intricate clinical interplay, addressing the global AMR threat, and enhancing future outcomes necessitate collaborative efforts across sectors, ongoing innovation, and educational initiatives.

Opportunities for AMR education for clinicians, caregivers, patients, and the public are viewed by 77% of healthcare executives as necessary for combating AMR. Participation in the Sepsis Alliance AMR Conference offers a unique opportunity for attendees to explore innovative ideas, gain inspiration, and learn about practical technologies to manage sepsis and counteract the expanding challenge of antimicrobial resistance.

Topics covered will include:

  • A One Health approach to combating AMR;
  • Maternal and pediatric AMR;
  • AMR in ambulatory and outpatient settings;
  • The role of Sepsis Teams in AMS.

Learning Objectives:

At the conclusion of this event, learners will be able to:

  • Explain the intricate link between sepsis and antimicrobial resistance;
  • Identify tools and resources to champion responsible antimicrobial prescribing practices;
  • Describe the pivotal role of healthcare executives and leadership in prioritizing, endorsing, and advancing stewardship efforts addressing antimicrobial resistance and sepsis;
  • Restate methods for leadership to actively pursue inventive approaches that engage healthcare providers in initiatives aimed at tackling antimicrobial resistance and enhancing sepsis management.

FREE Nursing CE Credits Offered! 

Continuing nursing education credits will be available, as will post-event access to resources, ideas, and innovations to improve sepsis care and antimicrobial stewardship. Sepsis Alliance is a Provider approved by the California Board of Registered Nursing, Provider Number CEP17068.

Conference Supporters:

Sepsis Alliance gratefully acknowledges the support provided for this conference by the following sponsors:

image       image         image


April 10, 2024

Time (ET)Session TitlePresenter
10:00-10:15Opening Remarks
10:55-11:25One Health in Action: Minnesota’s Collaborative Approach to Antibiotic Stewardship (CE Session)Kristen Clark, DVM, MPH, DACVPM, CCRT
Director, Minnesota One Health Antibiotic Stewardship Collaborative, Minnesota Department of Health
11:30-12:00Sponsor Track 1: Recce Pharmaceuticals Sponsored Session: Beyond Existing Antibiotics: Finding a Solution to AMR and SepsisJames Graham
Managing Director & Chief Executive Officer, Recce Pharmaceuticals
12:15-12:45Details Coming Soon
12:50-1:20Details Coming Soon

1:25-1:55Sponsor Track 1: bioMérieux Sponsored Session (Details Coming Soon)


2:10-2:40The Epidemiology of Antimicrobial Resistant Bacteria in the Pediatric Population (CE Session) 
Rachel Medernach, MD, MSCI
Assistant Professor, Rush University Medical Center
Details Coming Soon
Sponsor Session (Details Coming Soon)

3:40-3:55Sponsor Session (Details Coming Soon)

3:55-4:25Antimicrobial Stewardship: Important to All (CE Session)Alyssa R. Letourneau, MD, MPH, FIDSA
Assistant Professor of Medicine, Harvard Medical School
4:35-4:50Closing Remarks

April 11, 2024

Time (ET)Session TitlePresenter
10:00-10:15Welcome and Opening Remarks
11:55-11:25Details Coming Soon
11:30-12:00Sponsor Track 1: BD Sponsored Session: The Vital Role of Blood Culture Quality & Phenotypic ID/AST Results on Sepsis Patient Outcomes
Masashi Waga
Technical Director, Clinical Microbiology and Senior Manager, Clinical Microbiology
12:00 - 12:15Break
Antibiotic Resistance and Cancer: Challenges and Potential Solutions (CE Session)
David Greenberg, MD
Professor of Infectious Diseases and Microbiology, UT Southwestern
12:50-1:20Details Coming Soon
1:25-1:40Sponsor Session (Details Coming Soon)
1:45-2:00Sponsor Session (Details Coming Soon)
2:15-2:45Decolonization to Prevent Serious Infections and Antibiotic Resistant Pathogens: Extending the Benefit to Long-Term Care (CE Session)Susan Huang, MD MPH
Chancellor’s Professor, University of California Irvine School of Medicine
2:50-3:20Candida auris: A Global Emerging Multidrug Resistant Pathogen (CE Session)Mahmoud A. Ghannoum, PhD, MBA, FIDSA, FAAM
Professor, Case Western Reserve University and University Hospitals Cleveland Medical Center
3:25-3:55Sponsor Session (Details Coming Soon)
4:00-4:30The Need for and Approaches to Outpatient Antibiotic Stewardship (CE Session)Rachel Zetts, MPH
Senior Officer, Antibiotic Resistance Project, The Pew Charitable Trusts
4:35-4:50Closing Remarks